US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Health Care AlphaDEX Fund

129.21

-1.7400-1.33%

Pre-market: 130.251.04+0.80%04:24 EDT

Volume:45.60K

Turnover:5.91M

Market Cap:1.13B

PE:- -

High:131.98

Open:131.61

Low:129.00

Close:130.95

52wk High:135.82

52wk Low:104.53

Shares:8.75M

Float Shares:8.75M

Volume Ratio:1.44

T/O Rate:0.52%

Dividend:0.74

Dividend Rate:0.57%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Organon announces U.S. FDA accepted for review Sebela’s sNDA for Miudella

Organon Says FDA Accepts Miudella IUD sNDA for 6-Year Use Review

Organon & Co. - Miudella Anticipated to be Commercially Available in Late 2026

THOMSON REUTERS

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for Miudella®, a Hormone-Free Intrauterine Device

THOMSON REUTERS

Organon & Co. - Pdufa Action Expected in Q2 2027 for Miudella Snda

THOMSON REUTERS

Humana Inc. Stock Outperforms Competitors on Strong Trading Day

BofA Adjusts Price Target on Humana to $510 From $500

MT Newswires Live

Hongkou Pioneers 'Automatic Benefits' for Veterans' Medical Subsidies, Eliminating Paperwork Trips

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

Analysts Are Bullish on These NA Stocks: Securitize (SECZ), Humana (HUM)

Ambea Completes Share Buyback to Fund Humana Takeover Bid

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them

Bernstein Keeps Their Buy Rating on Humana (HUM)

Humana Inc. Stock Outperforms Competitors on Strong Trading Day

Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them

Humana Declares Q3 2026 Dividend of R$ 0.07 Per Unit, Payable Dec. 3

Thyme Care Closes Series E Financing Round of over $125 Million

Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/FXH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","market":"US","secType":"STK","nameCN":"First Trust Health Care AlphaDEX Fund","latestPrice":129.21,"timestamp":1791316800000,"preClose":130.95,"halted":0,"volume":45597,"hourTrading":{"tag":"盘前","latestPrice":130.25,"preClose":129.21,"latestTime":"04:24 EDT","volume":2,"amount":260.5,"timestamp":1791361455138,"change":1.04,"changeRate":0.008049,"amplitude":0},"delay":0,"changeRate":-0.013287514318442007,"floatShares":8750002,"shares":8750002,"eps":0,"marketStatus":"Pre-Mkt","change":-1.74,"latestTime":"10-07 06:31:36 EDT","open":131.61,"high":131.98,"low":128.9984,"amount":5911340.9904000005,"amplitude":0.022769,"askPrice":148.49,"askSize":100,"bidPrice":111.62,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791379800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":129.21,"sharesOutstanding":7900002,"nav":130.98,"aum":1146075261.96,"dividendRate":0.0057,"bidAskSpread":0.000811,"preHourTrading":{"tag":"盘前","latestPrice":130.25,"preClose":129.21,"latestTime":"04:24 EDT","volume":2,"amount":260.5,"timestamp":1791361455138,"change":1.04,"changeRate":0.008049,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":129.21,"preClose":129.21,"latestTime":"19:30 EDT","volume":15,"amount":1937.04,"timestamp":1791329402931,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.4411188391926657,"impliedVol":0.1896,"impliedVolPercentile":0.868},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","floatShares":8750002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.4411188391926657,"shares":8750002,"dividePrice":0.7365,"high":131.98,"amplitude":0.022769,"preClose":130.95,"low":128.9984,"week52Low":104.525,"pbRate":"--","week52High":135.8199,"institutionHeld":0,"latestPrice":129.21,"eps":0,"divideRate":0.0057,"volume":45597,"delay":0,"ttmEps":0,"open":131.61,"prevYearClose":113.8213,"prevWeekClose":129.51,"prevMonthClose":130.74,"prevQuarterClose":130.74,"fiveDayClose":131.27,"twentyDayClose":130.7,"sixtyDayClose":123.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FXH\",params:#limit:5,,,undefined,":[{"date":"2026-09-24","symbol":"FXH","amount":0.2917,"announcedDate":"2026-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-24","defaultRemindTime":1790256600000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-24","currency":"USD","dateTimestamp":1790222400000,"payDate":"2026-09-30"},{"date":"2026-06-25","symbol":"FXH","amount":0.1183,"announcedDate":"2026-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FXH","amount":0.1858,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FXH","amount":0.1399,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FXH","amount":0.5821,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FXH\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-23","recordDate":"2022-09-26","paymentDate":"2022-09-30","value":0.1007,"currency":"USD"},{"executeDate":"2022-12-23","recordDate":"2022-12-27","paymentDate":"2022-12-30","value":0.1214,"currency":"USD"},{"executeDate":"2023-03-24","recordDate":"2023-03-27","paymentDate":"2023-03-31","value":0.0438,"currency":"USD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-06-30","value":0.0377,"currency":"USD"},{"executeDate":"2023-09-22","recordDate":"2023-09-25","paymentDate":"2023-09-29","value":0.0332,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FXH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667631396","title":"Organon announces U.S. FDA accepted for review Sebela’s sNDA for Miudella","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631396","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667631396?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385762,"startTime":"0","endTime":"0","summary":"Organon (OGN) announced the US Food and Drug Administration, FDA, has accepted for review Sebela Women’s Health’s supplemental New Drug Application...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organon-announces-u-s-fda-accepted-for-review-sebelas-snda-for-miudella-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organon-announces-u-s-fda-accepted-for-review-sebelas-snda-for-miudella-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065170008.USD","OGN","LABU","BK4559","BK4585","BK4588","LU2065171402.SGD","LU2065169927.USD","BK4007","LU2065171311.SGD","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638496","title":"Organon Says FDA Accepts Miudella IUD sNDA for 6-Year Use Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638496","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667638496?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:32","pubTimestamp":1789385526,"startTime":"0","endTime":"0","summary":"Organon says FDA accepts Miudella IUD sNDA for 6-year use reviewFDA accepted for review an sNDA seeking to extend MIUDELLA copper IUD use to 6 years.PDUFA action date expected in Q2 2027.Organon licen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL6cwFt8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","BK4585","BK4559","BK4007","LU2065169927.USD","OGN","LU2065171311.SGD","BK4588","FXH","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667966877","title":"Organon & Co. - Miudella Anticipated to be Commercially Available in Late 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667966877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667966877?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:30","pubTimestamp":1789385400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABMRNXP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","LU2065170008.USD","LU2065171402.SGD","LU2065169927.USD","OGN","LU2065171311.SGD","BK4585","BK4007","FXH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667729668","title":"Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for Miudella®, a Hormone-Free Intrauterine Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2667729668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667729668?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:30","pubTimestamp":1789385400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABMRNXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4588","OGN","LU2065171402.SGD","BK4585","LU2065170008.USD","LU2065169927.USD","LU2065171311.SGD","FXH","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668771","title":"Organon & Co. - Pdufa Action Expected in Q2 2027 for Miudella Snda","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668771","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668771?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:30","pubTimestamp":1789385400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUABMRNXP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","OGN","FXH","LU2065170008.USD","LU2065171402.SGD","BK4588","BK4007","LU2065171311.SGD","BK4585","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666480574","title":"Humana Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666480574","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666480574?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:51","pubTimestamp":1789159860,"startTime":"0","endTime":"0","summary":"DJ Humana Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Humana Inc.  advanced 2.26% to $409.80 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.86% to 7,656.98 and the Dow Jones Industrial Average  rising 0.98% to 52,573.29.This was the stock's second consecutive day of gains.Humana Inc. closed 4.45% below its 52-week high of $428.88, which the company reached on July 16th.The stock outperformed some of its competitors Friday, as UnitedHealth Group Inc.  fell 2.37% to $379.09, Elevance Health Inc.  rose 0.52% to $418.72, and Chubb Ltd.  rose 0.18% to $338.25.Trading volume  remained 572,015 below its 50-day average volume of 1.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","HUM","LU0348723411.USD","SG9999014021.USD","BK4585","BK4588","BK4566","LU0211331839.USD","LU0238689110.USD","LU1093756168.USD","LU0070302665.USD","IHF","LU0256863811.USD","SG9999014013.SGD","LU0170899867.USD","LU0266013472.USD","LU0320765489.SGD","SG9999014005.SGD","LU1983260115.SGD","FXH","LU0208291251.USD","BK4154","BK4533","LU0390134368.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666952424","title":"BofA Adjusts Price Target on Humana to $510 From $500","url":"https://stock-news.laohu8.com/highlight/detail?id=2666952424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666952424?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:32","pubTimestamp":1789129978,"startTime":"0","endTime":"0","summary":"Humana (HUM) has an average rating of overweight and mean price target of $420.96, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IHF","LU0208291251.USD","LU0211331839.USD","LU0238689110.USD","HUM.AU","LU0348723411.USD","HUM","LU0390134368.USD","BK7500","SG9999014021.USD","BK4154","LU0256863811.USD","LU1093756325.SGD","LU0320765489.SGD","BK4566","FXH","SG9999014013.SGD","SG9999014005.SGD","BK4588","LU0170899867.USD","LU0417517546.SGD","LU1983260115.SGD","BK7093","BK4585","LU0070302665.USD","LU1093756168.USD","LU0266013472.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143905444","title":"Hongkou Pioneers 'Automatic Benefits' for Veterans' Medical Subsidies, Eliminating Paperwork Trips","url":"https://stock-news.laohu8.com/highlight/detail?id=1143905444","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143905444?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:11","pubTimestamp":1789038664,"startTime":"0","endTime":"0","summary":"Veterans in Hongkou District can now receive medical subsidies without submitting paper invoices or visiting service stations, marking a significant step in streamlining administrative procedures....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266013472.USD","LU1983260115.SGD","LU0208291251.USD","LU1093756168.USD","HUM","BK4154","IHF","SG9999014005.SGD","LU0170899867.USD","RSPH","FXH","LU0348723411.USD","LU0211331839.USD","BK4566","LU0320765489.SGD","LU0390134368.USD","LU0070302665.USD","LU1093756325.SGD","LU0256863811.USD","BK4585","BK4533","SG9999014013.SGD","LU0238689110.USD","BK4588","SG9999014021.USD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZNH","CNCR","FTXH","NVIB","MEDX","FHLC","GNMX","PJP","MEDI","IDNA","LLYX","BBH","PINK","CANC","FXH","FBT","HRTS","SBIO","SYNB","GDOC","APXH","MDTX","BBP","JDOC","PSCH","BIB","SURI","HYLG","PBE","TBXU","BME","IBBQ","GNOM","JHMH","MRNY","IBBJ","XPH","PTH","CURE","WDNA","MNTL","LFSC","PSIL","IEIH","IBB","PBPH","GSKH","IBRN","RSPH","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FXH","JHMH","MEDX","RSPH","MEDI","BBP","HRTS","SYNB","HYLG","TBXU","MNTL","PJP","FHLC","GSKH","BME","PBPH","IBBQ","GPCR","IDNA","SURI","MDTX","JDOC","GNMX","GDOC","PTH","GNOM","IBRN","MRNY","PSCH","AZNH","LENZ","BIB","NVIB","PSIL","CANC","FBT","LLYX","SBIO","WDNA","XPH","IBBJ","CURE","IBB","APXH","BBH","LFSC","PBE","CNCR","FTXH","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665290543","title":"Analysts Are Bullish on These NA Stocks: Securitize (SECZ), Humana (HUM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665290543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665290543?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:40","pubTimestamp":1788860419,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Securitize (SECZ) and Humana (HUM) with bullish sentiments. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-na-stocks-securitize-secz-humana-hum-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-na-stocks-securitize-secz-humana-hum-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","LU0070302665.USD","IHF","NA","LU0208291251.USD","LU1983260115.SGD","SG9999014005.SGD","BK4566","BK4585","LU1093756168.USD","BK4588","SECZ","BK4141","LU0348723411.USD","BK4533","BK4154","LU0390134368.USD","HUM","SG9999014013.SGD","SG9999014021.USD","LU0238689110.USD","FXH","LU0417517546.SGD","LU0320765489.SGD","BK4127","LU0170899867.USD","LU0211331839.USD","LU0266013472.USD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665258433","title":"Ambea Completes Share Buyback to Fund Humana Takeover Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2665258433","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665258433?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:30","pubTimestamp":1788856225,"startTime":"0","endTime":"0","summary":"Ambea completes share buyback to fund Humana takeover bidAmbea completed its share repurchase program tied to its recommended public offer for Humana shareholders, securing the targeted number of trea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9L7xyw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU0070302665.USD","IHF","LU0208291251.USD","LU1983260115.SGD","SG9999014005.SGD","BK4566","BK4585","LU1093756168.USD","BK4588","LU0348723411.USD","BK4533","BK4154","LU0390134368.USD","HUM","SG9999014013.SGD","SG9999014021.USD","LU0238689110.USD","FXH","LU0417517546.SGD","LU0320765489.SGD","LU0170899867.USD","LU0211331839.USD","LU0266013472.USD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","CURE","MEDI","BGIA","NBDS","NVOX","PINK","RSPH","NVOC","FXH","FHLC","NVOH","THNR","TRUH","XLVI","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665458363","title":"Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them","url":"https://stock-news.laohu8.com/highlight/detail?id=2665458363","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665458363?lang=en_us&edition=fundamental","pubTime":"2026-09-05 22:15","pubTimestamp":1788617700,"startTime":"0","endTime":"0","summary":"The annual Medicare open-enrollment period runs from Oct. 15 to Dec. 7Medicare Advantage plans cover more than half of the total Medicare market of 70.5 million subscribers, according to the Centers f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","FXH","LU0208291251.USD","BK4585","XLVX","LU0238689110.USD","IEHS","LU0348723411.USD","SG9999014013.SGD","LU0070302665.USD","HUM","LU0256863811.USD","LU0170899867.USD","LU0417517546.SGD","LU1983260115.SGD","LU0320765489.SGD","LU0211331839.USD","LU1093756168.USD","UN","IYH","LU0266013472.USD","LU1093756325.SGD","BK4154","XHS","IHF","SG9999014021.USD","UNHU","LNGR","BK4533","UNHG","BK4588","SG9999014005.SGD","LU0390134368.USD","UNHW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339551","title":"Bernstein Keeps Their Buy Rating on Humana (HUM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339551","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339551?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:17","pubTimestamp":1788520629,"startTime":"0","endTime":"0","summary":"Bernstein analyst Lance Wilkes maintained a Buy rating on Humana today and set a price target of $425.00. Wilkes covers the Healthcare sector, focu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-keeps-their-buy-rating-on-humana-hum-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-keeps-their-buy-rating-on-humana-hum-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0211331839.USD","LU0417517546.SGD","SG9999014021.USD","LU0256863811.USD","XBI","LU0348723411.USD","BK4566","LU0170899867.USD","LU0070302665.USD","LU1093756325.SGD","BK4588","LABU","XLV","LU0208291251.USD","HUM","FXH","IHF","LU0266013472.USD","BK4533","LU1093756168.USD","LU1983260115.SGD","LU0390134368.USD","BK4154","LU0238689110.USD","SG9999014013.SGD","BK4585","BK4581","SG9999014005.SGD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664804370","title":"Humana Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804370?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:52","pubTimestamp":1788468720,"startTime":"0","endTime":"0","summary":"DJ Humana Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Humana Inc.  rallied 1.38% to $406.52 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.06% to 7,747.71 and the Dow Jones Industrial Average  rising 1.18% to 53,686.11.This was the stock's third consecutive day of gains.Humana Inc. closed 5.21% short of its 52-week high of $428.88, which the company reached on July 16th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as UnitedHealth Group Inc.  rose 0.32% to $400.94, Elevance Health Inc.  rose 2.20% to $414.78, and Chubb Ltd.  rose 2.60% to $348.25.Trading volume  remained 550,681 below its 50-day average volume of 1.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0417517546.SGD","LU0170899867.USD","LU0211331839.USD","LU1093756325.SGD","SG9999014021.USD","LU0348723411.USD","SG9999014005.SGD","BK4585","LU0390134368.USD","BK4566","LU0320765489.SGD","BK4533","FXH","LU0070302665.USD","HUM","BK4154","IHF","SG9999014013.SGD","LU1093756168.USD","LU0256863811.USD","LU0238689110.USD","LU0208291251.USD","LU1983260115.SGD","LU0266013472.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805403","title":"Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805403","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805403?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:23","pubTimestamp":1788456180,"startTime":"0","endTime":"0","summary":"The annual Medicare open-enrollment period runs from Oct. 15 to Dec. 7Medicare Advantage plans cover more than half of the total Medicare market of 70.5 million subscribers, according to the Centers f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","SG9999014005.SGD","LU1093756168.USD","XHS","SG9999014013.SGD","FXH","UNHW","BK4566","HUM","LU0170899867.USD","LU0266013472.USD","IHF","UNHG","BK4533","LU0208291251.USD","BK4585","LNGR","UN","LU1983260115.SGD","SG9999014021.USD","BK4154","IYH","LU1093756325.SGD","LU0390134368.USD","XLVX","LU0417517546.SGD","IEHS","BK4588","LU0211331839.USD","LU0256863811.USD","LU0320765489.SGD","LU0348723411.USD","UNHU","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664480850","title":"Humana Declares Q3 2026 Dividend of R$ 0.07 Per Unit, Payable Dec. 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2664480850","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664480850?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:49","pubTimestamp":1788446961,"startTime":"0","endTime":"0","summary":"Humana declares Q3 2026 dividend of R$ 0.07 per unit, payable Dec. 3Humana declared a 3Q 2026 dividend of R$ 0.07 per unit.Shares trade with entitlement through Oct. 28, 2026.Dividend payable on Dec. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLbBXf5m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","LU0256863811.USD","BK4585","LU0170899867.USD","LU0390134368.USD","LU0070302665.USD","LU1093756168.USD","LU1093756325.SGD","LU0238689110.USD","LU1983260115.SGD","LU0320765489.SGD","BK4154","LU0208291251.USD","LU0348723411.USD","SG9999014005.SGD","SG9999014021.USD","HUM","FXH","BK4566","BK4588","SG9999014013.SGD","LU0417517546.SGD","IHF","LU0266013472.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843336","title":"Thyme Care Closes Series E Financing Round of over $125 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843336","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843336?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:29","pubTimestamp":1788366540,"startTime":"0","endTime":"0","summary":"BRIEF-Thyme Care Closes Series E Financing Round Of Over $125 MillionSept 2 (Reuters)-THYME CARE:THYME CARE: CLOSES SERIES E FINANCING ROUND OF OVER $125 MILLIONTHYME CARE: MORGAN HEALTH, CVS HEALTH V","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U02N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUM","BK4154","LU0432979614.USD","LU0006061336.USD","SG9999014013.SGD","LU1236620834.HKD","LU0256863811.USD","IE00B19Z3581.USD","IHF","BK4504","LU0170899867.USD","BK4588","CVS","LU0266013472.USD","IE00BKVL7J92.USD","IE0002270589.USD","LU0859254822.USD","BK4585","IE00B7SZLL34.SGD","LU0320765489.SGD","IE00BSNM7G36.USD","BK4581","FXH","LU2125909247.SGD","LU1059921491.USD","LU1571399168.USD","LU1983299246.USD","LU2433249047.HKD","LU0072461881.USD","IE00BZ1G4Q59.USD","BK4196","LU1093756168.USD","LU0238689110.USD","BK4550","LU2357627491.SGD","LU0390134368.USD","LU1983260115.SGD","LU1923622614.USD","BK4566","LU0061475181.USD","LU1236620750.USD","RTH","LU0211331839.USD","LU0348723411.USD","LU0070302665.USD","LU0162691827.USD","LU2125909593.SGD","LU1093756325.SGD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664443848","title":"Medicare Advantage Patients Who Get Diagnosed with Alzheimer's or Other Serious Diseases are Ditching Their Plans - and it Can Cost Them","url":"https://stock-news.laohu8.com/highlight/detail?id=2664443848","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664443848?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:04","pubTimestamp":1788365040,"startTime":"0","endTime":"0","summary":"The annual Medicare open-enrollment period runs from Oct. 15 to Dec. 7Medicare Advantage plans cover more than half of the total Medicare market of 70.5 million subscribers, according to the Centers f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","FXH","LU0208291251.USD","BK4585","XLVX","LU0238689110.USD","IEHS","LU0348723411.USD","SG9999014013.SGD","LU0070302665.USD","HUM","LU0256863811.USD","LU0170899867.USD","LU0417517546.SGD","LU1983260115.SGD","LU0320765489.SGD","LU0211331839.USD","LU1093756168.USD","UN","IYH","LU0266013472.USD","LU1093756325.SGD","BK4154","XHS","IHF","SG9999014021.USD","UNHU","LNGR","BK4533","UNHG","BK4588","SG9999014005.SGD","LU0390134368.USD","UNHW"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}